BCL2 and breast cancer: Crude venom exhibits broad-spectrum cytotoxicity across various breast cancer cell lines, primarily through the upregulation of pro-apoptotic markers (e.g., Bax, Caspase-3) and the downregulation of anti-apoptotic markers (e.g., Bcl-2).